Hereditary Cancer
Cancer Wellness Panel
Beyond environment and lifestyle, inherited factors play an important role in cancer. This panel assesses hereditary breast, ovarian, pancreatic and prostate cancer, male breast cancer, primary peritoneal and fallopian tube cancer, Li-Fraumeni syndrome and other hereditary tumour risks, so screening and prevention can be planned around your own genetics.

DETECTION ITEMS
Diseases Covered
Hereditary Breast Cancer
Women onlyHereditary Breast Cancer
BRCA1 carriers face a lifetime risk of about 60-80% and BRCA2 carriers 40-70%, far above the 12% general population risk, with markedly earlier onset.
Ovarian Cancer
Women onlyOvarian Cancer
Known as the "silent killer" because early disease has almost no symptoms; lifetime risk is about 40-60% for BRCA1 carriers and 15-25% for BRCA2.
Fallopian Tube Cancer
Women onlyFallopian Tube Cancer
Many BRCA-related tumours once diagnosed as ovarian cancer in fact begin at the fallopian tube fimbriae, so the two are managed as one disease spectrum.
Primary Peritoneal Carcinoma
Primary Peritoneal Carcinoma
Arises on the peritoneal surface but is pathologically identical to BRCA-related ovarian cancer; a 1-4% lifetime risk remains even after risk-reducing salpingo-oophorectomy.
Male Breast Cancer
Men onlyMale Breast Cancer
Rare, but BRCA2 raises a man's lifetime risk to 5-10% — roughly 80-100 times the general male risk — and low awareness often delays diagnosis.
Prostate Cancer
Men onlyProstate Cancer
BRCA2 carriers have a lifetime risk of about 20-30%, and their tumours are more aggressive and more likely to metastasise, so earlier PSA screening is advised.
Pancreatic Cancer
Pancreatic Cancer
BRCA2 carriers have a lifetime risk of about 3-7%, several times that of the general population. Early disease is almost symptomless and over 80% of cases are advanced at diagnosis.
Li-Fraumeni Syndrome
Li-Fraumeni Syndrome
A high-penetrance hereditary cancer syndrome caused by germline TP53 variants, with cumulative lifetime cancer risk up to 90% in women and 73% in men, very early onset and multiple primary tumours.
Osteosarcoma
Osteosarcoma
The most common malignant bone tumour in Li-Fraumeni syndrome, typically around the knee, presenting as bone pain that is worse at night plus local swelling.
Soft Tissue Sarcoma
Soft Tissue Sarcoma
Includes rhabdomyosarcoma and malignant peripheral nerve sheath tumour among other subtypes; one of the most common LFS tumours, usually a rapidly growing painless lump.
Adrenocortical Carcinoma
Adrenocortical Carcinoma
Li-Fraumeni syndrome accounts for 50-80% of childhood adrenocortical carcinoma. The tumour may oversecrete steroid hormones, producing Cushing's syndrome or virilisation.
Brain Tumors
Brain Tumors
LFS-related brain tumours are mainly astrocytoma and choroid plexus tumour, with earlier onset and high sensitivity to radiotherapy.
PROCESS
Testing Process
Four simple steps to complete professional genetic testing
Book Consultation
Assessment and consultation with medical professionals
Sample Collection
Simple oral mucosa sampling
Laboratory Testing
Professional gene sequence analysis
Report Interpretation
Detailed explanation by medical professionals
More Information
Contact us for full details of the Cancer Wellness Panel and the testing process
Contact Us
